Cargando…
Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed
Cardiovascular diseases represent the first cause of morbidity in Western countries, and chronic heart failure features a significant health care burden in developed countries. Efforts in the attempt of finding new possible strategies for the treatment of CHF yielded several approaches based on the...
Autores principales: | Passaro, Fabiana, Testa, Gianluca, Ambrosone, Luigi, Costagliola, Ciro, Tocchetti, Carlo Gabriele, di Nezza, Francesca, Russo, Michele, Pirozzi, Flora, Abete, Pasquale, Russo, Tommaso, Bonaduce, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742458/ https://www.ncbi.nlm.nih.gov/pubmed/29375623 http://dx.doi.org/10.1155/2017/4940397 |
Ejemplares similares
-
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes
por: Testa, Gianluca, et al.
Publicado: (2020) -
Implications of Cellular Aging in Cardiac Reprogramming
por: Passaro, Fabiana, et al.
Publicado: (2018) -
Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction
por: Pirozzi, Flora, et al.
Publicado: (2015) -
Depression and chronic heart failure in the elderly: an intriguing relationship
por: Liguori, Ilaria, et al.
Publicado: (2018) -
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
por: Molinaro, Marilisa, et al.
Publicado: (2015)